Synermore

Recent Finacing

Equity

Recent Raise

Undisclosed

Synermore conducts R&D in oncology, infectious and immune diseases, develops drugs and biosimilar monoclonal antibodies, and advances candidates through IND‑supporting nonclinical studies and CMC into clinical trials.